| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/27/2006 | CN1886141A T-type calcium channel inhibitor |
| 12/27/2006 | CN1886120A Method for the production of a solid, orally applicable pharmaceutical composition |
| 12/27/2006 | CN1883640A Medicine for treating leucocytopenia caused after tumor radiotherapy and chemotherapy |
| 12/27/2006 | CN1883593A Blood-nourishing oral liquid with nine ingredients |
| 12/27/2006 | CN1883516A Pharmaceutical composition of 'Yunnan Baiyao' for replenishing kidney, strengthening waist, resisting inflammation, dissipating stasis and anaesthesia to ease pain |
| 12/27/2006 | CN1883504A Medium and method for preserving platelets, red blood cells, and other non-nucleus cells and platelets-containing composition |
| 12/27/2006 | CN1883498A Compound puerarin for treating cardiovascular and cerebrovascular disease |
| 12/27/2006 | CN1883496A Solid-state molecular dispersible prepration of pennogenin compound |
| 12/27/2006 | CN1883495A Solid-state molecular dispersible preparation of pennogenin compound |
| 12/27/2006 | CN1883494A Solid-state molecular dispersible preparation of pennogenin compound |
| 12/27/2006 | CN1883493A Solid-state molecular dispersible preparation of pennogenin compound |
| 12/27/2006 | CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors |
| 12/27/2006 | CN1291756C Blood cell production via activation of hemeglobin scavenger receptor |
| 12/27/2006 | CN1291746C Chinese medicine preparation for treating hematophilia |
| 12/27/2006 | CN1291726C Application of ligusticum oil in preparation of medicine for treating cerebral thrombosis |
| 12/27/2006 | CN1291718C Remedy for acute myocardial infarction |
| 12/26/2006 | US7153881 Compounds acting as melanocortin receptor ligands |
| 12/26/2006 | US7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
| 12/26/2006 | US7153822 Compositions and methods for modulating connexin hemichannels |
| 12/21/2006 | WO2006135621A2 Method for renin-angiotensin-aldosterone system activation and control thereof |
| 12/21/2006 | WO2006135323A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
| 12/21/2006 | WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | WO2006135080A1 Thienopyrimidine derivative |
| 12/21/2006 | WO2006134877A1 Injection |
| 12/21/2006 | WO2006134828A1 Anion adsorbent, agent for purifying water or soil, and method for producing those |
| 12/21/2006 | WO2006133955A1 Adamts13-comprising compositions having thrombolytic activity |
| 12/21/2006 | WO2006089005A3 Combination of selective factor viia and/or xia and plasma kallikrein inhibitors |
| 12/21/2006 | WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 12/21/2006 | WO2006023397A3 Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| 12/21/2006 | WO2006005058A3 Polymer-factor ix moiety conjugates |
| 12/21/2006 | US20060287538 Process for the preparation of amorphous calcium salt of atorvastatin |
| 12/21/2006 | US20060287329 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide |
| 12/21/2006 | US20060287249 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors |
| 12/21/2006 | US20060287236 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 12/21/2006 | US20060287228 Expression of active human factor IX in mammary tissue of transgenic animals |
| 12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | CA2611917A1 Injection |
| 12/21/2006 | CA2610429A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | CA2610428A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
| 12/21/2006 | CA2606351A1 Adamts13-comprising compositions having thrombolytic activity |
| 12/20/2006 | EP1734116A2 Thrombin derivatives and medicinal composition containing the same |
| 12/20/2006 | EP1734051A2 Composition and methods for the diagnosis of tumours |
| 12/20/2006 | EP1734041A2 Platelet ADP receptor inhibitors |
| 12/20/2006 | EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol" |
| 12/20/2006 | EP1733726A1 Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | EP1733724A1 Amino alcohol compound |
| 12/20/2006 | EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor |
| 12/20/2006 | EP1733058A2 Iron sucrose complexes and method of manufacture thereof |
| 12/20/2006 | EP1732932A1 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same |
| 12/20/2006 | EP1732918A1 Novel pyrrolidine-3,4-dicarboxamide derivatives |
| 12/20/2006 | EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1317537B1 G-csf analog compositions and methods |
| 12/20/2006 | EP1272457B9 Compounds for modulating cell proliferation |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 12/20/2006 | CN1882575A Substituted pyrrole-indoles as inhibitors of PAI-1 |
| 12/20/2006 | CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors |
| 12/20/2006 | CN1882357A Therapeutic use of factor XI |
| 12/20/2006 | CN1882337A Substituted oxadiazolidinediones ALS PAI-1 inhibitors |
| 12/20/2006 | CN1882336A Substituted oxadiazolidinediones |
| 12/20/2006 | CN1882329A 4-(1-benzofuran-3-yl-methylideneaminoxy.propoxy))-benzoic acid derivatives and related compounds as PAI-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis |
| 12/20/2006 | CN1882324A Substituted aryloximes |
| 12/20/2006 | CN1882323A Substituted benzofuran oximes |
| 12/20/2006 | CN1880458A Human source chromosome targeting vector of human beta-globin gene cluster and application therefor |
| 12/20/2006 | CN1880451A Method for preparing recombinant aprotinin |
| 12/20/2006 | CN1880446A Antibody complexes |
| 12/20/2006 | CN1880334A High purity albumin production process |
| 12/20/2006 | CN1879870A Soup formulation for treating spleen and kidney Yang defect type cirrhosis ascites, and its preparation method |
| 12/20/2006 | CN1879866A Soup formulation for treating liver and spleen blood stasis defect type cirrhosis ascites, and its preparation method |
| 12/20/2006 | CN1879864A Soup formulation for treating liver and kidney Yin defect type cirrhosis ascites, and its preparation method |
| 12/20/2006 | CN1879855A A soft capsule of 'Xiao Chai Hu' and method for preparing same |
| 12/20/2006 | CN1879853A A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same |
| 12/20/2006 | CN1879756A Quality control method of kidney-replenishing blood-nourishing soft capsule |
| 12/20/2006 | CN1879720A Blood platelet-increasing tablet, its preparation process and quality control method |
| 12/20/2006 | CN1879714A A Chinese medicinal composition for treating thrombus |
| 12/20/2006 | CN1879643A Pennogenic compound liquid molecular dispersible preparation |
| 12/20/2006 | CN1879642A Pennogenin compound liquid molecular dispersible preparation |
| 12/20/2006 | CN1879639A A nanometer 'Xue Shuan Tong' injection and preparation method thereof |
| 12/20/2006 | CN1879638A A nanometer 'Xue Sai Tong' injection and preparation method thereof |
| 12/20/2006 | CN1290907C A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290847C Aza-arylpiperazines |
| 12/20/2006 | CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/20/2006 | CN1290586C A haemostatic kit, a method of preparing a haemostatic agent |
| 12/20/2006 | CN1290574C Injection of donkey hide gelatin and its preparation |
| 12/20/2006 | CN1290541C Medicinal extract for tonifying kidney and enriching blood made from foetal fuzz, and its preparation method |
| 12/20/2006 | CN1290501C Pharmaceutically active isoindoline derivatives |
| 12/19/2006 | US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/19/2006 | US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 12/19/2006 | US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |
| 12/19/2006 | CA2251623C Buccal delivery system |
| 12/19/2006 | CA2190778C Transmucosal delivery system |
| 12/14/2006 | WO2006133391A2 Improved treatment for anemia using a hif-alpha stabilising agent |